novo glp-1 drug Blockbuster Diabetes and Weight Loss Drugs Fails in Alzheimer's Trial GLP-1 drugs protect against new
Description
Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members
Baranowska-Bik A (2022) Therapy of obesity in women with PCOS using GLP-1 analogues - benefits and limitations [Terapia otylosci u kobiet z PCOS przy zastosowaniu analogow GLP-1korzysci i ograniczenia]
Ueda P, et al
95% CI 1.16-2.58
[DOI] [PubMed] [Google Scholar] 76.Nandakoban H, Furlong TJ, Flack JR
It is important to discuss any new or worsening symptoms with your healthcare provider to ensure appropriate assessment and management
